MLTX logo

MoonLake Immunotherapeutics (MLTX) Retained Earnings

Annual Retained Earnings:

-$235.59M-$118.94M(-101.95%)
December 31, 2024

Summary

  • As of today, MLTX annual retained earnings is -$235.59 million, with the most recent change of -$118.94 million (-101.95%) on December 31, 2024.
  • During the last 3 years, MLTX annual retained earnings has fallen by -$181.95 million (-339.18%).
  • MLTX annual retained earnings is now -9261.56% below its all-time high of -$2.52 million, reached on December 1, 2020.

Performance

MLTX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Quarterly Retained Earnings:

-$330.76M-$55.22M(-20.04%)
June 30, 2025

Summary

  • As of today, MLTX quarterly retained earnings is -$330.76 million, with the most recent change of -$55.22 million (-20.04%) on June 30, 2025.
  • Over the past year, MLTX quarterly retained earnings has dropped by -$176.16 million (-113.95%).
  • MLTX quarterly retained earnings is now -6615040.00% below its all-time high of -$5000.00, reached on September 1, 2020.

Performance

MLTX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

MLTX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-102.0%-114.0%
3Y3 Years-339.2%-463.7%
5Y5 Years-9261.6%-10000.0%

MLTX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-339.2%at low-380.8%at low
5Y5-Year-9261.6%at low>-9999.0%at low
All-TimeAll-Time-9261.6%at low>-9999.0%at low

MLTX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$330.76M(-20.0%)
Mar 2025
-
-$275.54M(-17.0%)
Dec 2024
-$235.59M(-102.0%)
-$235.59M(-24.0%)
Sep 2024
-
-$189.99M(-22.9%)
Jun 2024
-
-$154.60M(-18.6%)
Mar 2024
-
-$130.33M(-11.7%)
Dec 2023
-$116.66M(-44.6%)
-$116.66M(-6.8%)
Sep 2023
-
-$109.22M(-9.4%)
Jun 2023
-
-$99.79M(-11.3%)
Mar 2023
-
-$89.66M(-11.2%)
DateAnnualQuarterly
Dec 2022
-$80.65M(-50.3%)
-$80.65M(-17.2%)
Sep 2022
-
-$68.79M(-17.2%)
Jun 2022
-
-$58.68M(-501.0%)
Mar 2022
-
-$9.76M(+81.8%)
Dec 2021
-$53.64M(-2031.6%)
-$53.64M(-1009.0%)
Sep 2021
-
-$4.84M(-1414.0%)
Jun 2021
-
-$319.50K(-91.2%)
Mar 2021
-
-$167.10K(+93.4%)
Dec 2020
-$2.52M
-$2.52M(>-9900.0%)
Sep 2020
-
-$5000.00

FAQ

  • What is MoonLake Immunotherapeutics annual retained earnings?
  • What is the all-time high annual retained earnings for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual retained earnings year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly retained earnings year-on-year change?

What is MoonLake Immunotherapeutics annual retained earnings?

The current annual retained earnings of MLTX is -$235.59M

What is the all-time high annual retained earnings for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual retained earnings is -$2.52M

What is MoonLake Immunotherapeutics annual retained earnings year-on-year change?

Over the past year, MLTX annual retained earnings has changed by -$118.94M (-101.95%)

What is MoonLake Immunotherapeutics quarterly retained earnings?

The current quarterly retained earnings of MLTX is -$330.76M

What is the all-time high quarterly retained earnings for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly retained earnings is -$5000.00

What is MoonLake Immunotherapeutics quarterly retained earnings year-on-year change?

Over the past year, MLTX quarterly retained earnings has changed by -$176.16M (-113.95%)
On this page